XBiotech Inc (XBIT) — Capital Reinvestment Ratio
Latest as of December 2022:
0.05x
XBiotech Inc (XBIT) has a Capital Reinvestment Ratio of 0.05x as of December 2022, meaning it reinvests 0% of its operating cash flow ($2.70 Million) in capital expenditures ($132.00K). See free cash flow generation of XBiotech Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
$2.70 Million
USD
Capital Expenditures
$132.00K
USD
Data as of
Dec 2022
Most recent filing
XBiotech Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks XBiotech Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for XBiotech Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for XBiotech Inc from 2021 to 2021. For live market cap and broader valuation context, see how much is XBiotech Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.05x | $69.44 Million | $3.52 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow